Journal
CIRCULATION RESEARCH
Volume 114, Issue 5, Pages 761-764Publisher
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1161/CIRCRESAHA.114.303398
Keywords
cardiovascular disease; cholesterol; diabetes; guidelines; low-density-lipoprotein; risk; treatment
Funding
- AstraZeneca
- Boerhinger-Ingelheim
- BristolMyersSquibb
- Genentech/Roche
- Genzyme
- ISIS
- Janssen
- Kowa
- Merck
- Novartis
- Pfizer
- Regeneron
- Sanofi